ArticleCureus2026
Indolent Progression of a Persistent Positron Emission Tomography (PET)-Negative Ground-Glass Pulmonary Nodule to Pulmonary Adenocarcinoma Following Nine Years of Radiographic Surveillance: A Case Report.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Indolent pulmonary adenocarcinoma spectrum lesions can remain radiographically stable for years and often demonstrate little to no fluorodeoxyglucose (FDG) uptake on positron emission tomography (PET), making diagnosis and management challenging. We report the case of a 74-year-old Caucasian woman with a remote five-year smoking history and a strong family history of lung cancer who was followed for a persistent right upper lobe ground-glass pulmonary nodule. Despite gradual enlargement, PET imaging performed seven years later demonstrated no significant FDG uptake. Serial computed tomography (CT) scans over the following years showed slow progression from a pure ground-glass nodule to a mixed ground-glass and part-solid lesion with an enlarging solid component, raising concern for an indolent adenocarcinoma. Transbronchial needle aspiration demonstrated atypical epithelioid cells, and immunohistochemical staining was positive for thyroid transcription factor-1 (TTF-1) and cytokeratin 7 (CK7) and negative for p40, confirming pulmonary adenocarcinoma. Repeat PET imaging two years later demonstrated mild FDG uptake despite histopathologic evidence of malignancy. This case highlights the prolonged radiographic evolution of a persistent ground-glass pulmonary nodule and demonstrates that limited FDG uptake does not exclude an indolent pulmonary neoplasm. Development or enlargement of a solid component within a persistent ground-glass nodule should prompt careful reassessment even when the metabolic activity remains low.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.